SHANGHAI, China and SINGAPORE, Jan. 05, 2022 (GLOBE NEWSWIRE) Shanghai Junshi Biociences Co., Ltd ("Junshi Biosciences", HKEX: 1877, SSE: 688180), a leading innovation-driven biopharmaceutical company
Junshi Biosciences and DotBio Announce Collaboration to Develop Next-Generation Antibody Therapy with DotBody Module | Comunicados | Edición USA efe.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from efe.com Daily Mail and Mail on Sunday newspapers.
05.01.2022 - SHANGHAI, China and SINGAPORE, Jan. 05, 2022 (GLOBE NEWSWIRE) - Shanghai Junshi Biociences Co., Ltd (“Junshi Biosciences”, HKEX: 1877, SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and . Seite 1